Detalhe da pesquisa
1.
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.
Circ Res;
127(7): 877-892, 2020 09 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32564710
2.
Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.
Diabetologia;
57(9): 1977-85, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24957662
3.
Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes.
Sci Rep;
13(1): 12948, 2023 08 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37558746
4.
Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
Diabetes;
71(9): 1994-2008, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35713929
5.
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition).
Endocrinol Diabetes Metab;
4(3): e00278, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34277994
6.
Short Duration Alagebrium Chloride Therapy Prediabetes Does Not Inhibit Progression to Autoimmune Diabetes in an Experimental Model.
Metabolites;
11(7)2021 Jun 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34203471
7.
Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure.
iScience;
24(11): 103308, 2021 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34820603
8.
Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
Sci Rep;
11(1): 9422, 2021 05 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33941808
9.
T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.
Diabetes;
70(8): 1754-1766, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34285121
10.
Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes.
Nutrients;
12(10)2020 Sep 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32987824
11.
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion.
Sci Rep;
9(1): 13664, 2019 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31541173
12.
Increased liver AGEs induce hepatic injury mediated through an OST48 pathway.
Sci Rep;
7(1): 12292, 2017 09 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28947796
13.
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.
Sci Rep;
7(1): 15190, 2017 11 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29123192
14.
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Sci Rep;
6: 26428, 2016 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27226136
15.
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Sci Rep;
6: 28124, 2016 07 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27389496